MBX Microbix Biosystems Inc.

0.2063USD0.2950 CAD · TSX+7.27%Mkt Cap: 28.25M USDP/E: —

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company m…

Insiders, last 90 days3 buys

Key Statistics

Company
Market Cap28.25M USD
Enterprise Value27.95M USD
Revenue (TTM)10.77M USD
Gross Profit6.89M USD
Net Income (TTM)-1.57M USD
Revenue/Share0.08 USD
Last Price0.2063 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA59501P1045
Valuation
P/E (Trailing)—
P/E (Forward)14.75
PEG—
EV/EBITDA-13.08
EV/Revenue2.60
P/S2.62
P/B1.67
EPS (TTM)-0.03 USD
EPS (Forward)0.01 USD
52W Range
0.146877% of range0.2238
52W High0.2238 USD
52W Low0.1468 USD
Profitability
Gross Margin53.02%
Oper. Margin-27.77%
EBITDA Margin-19.84%
Profit Margin-12.08%
ROE-8.08%
ROA-6.00%
ROIC-6.85%
ROCE-4.55%
Growth
Revenue Growth16.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-56.14K USD
CapEx (TTM)557.53K USD
FCF Margin-18.50%
FCF Yield-7.05%
Net Debt-307.73K USD
Net Debt/EBITDA0.14
Net Debt/FCF—
Balance Sheet
Debt/Equity0.24
Current Ratio6.89
Quick Ratio3.17
Book Value/Sh0.12 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield142.46%
Payout Ratio0.00%
Ex-Div DateSep 2, 1999
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.2797 USD
Upside (mean)+35.6%
Target Range0.2797 USD – 0.2797 USD
# Analysts1
Ownership
Shares Out.136.97M
Float114.04M
Insiders14.93%
Institutions0.00%
Short Interest
Short Ratio0.8d
Short % Out.0.02%
Shares Short21.12K
Short (prev mo.)5.22K
Technical
SMA 500.2126 (-3.0%)
SMA 2000.1939 (+6.4%)
Beta0.54
S&P 52W Chg12.00%
Avg Vol (30d)33.65K
Avg Vol (10d)40.36K
Technical Indicators
RSI (14)49.4
MACD-0.0038
MACD Signal-0.0032
MACD Hist.-0.0005
BB Upper0.2231 USD
BB Middle0.2070 USD
BB Lower0.1908 USD
BB Width15.59%
ATR (14)0.0083 USD
Vol Ratio (20d)0.10x

About Microbix Biosystems (TSE: MBX)

›

Microbix Biosystems (TSE: MBX) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.2950 CAD on 19 November 2026, up 18.0% over 52 weeks. Its 52-week range is 0.2100 CAD to 0.3200 CAD: the price is 7.8% below the high and 40.5% above the low.

Its market capitalisation is 40.41M CAD.

Microbix Biosystems reports return on equity of -8.1%, an operating margin of -27.8% and revenue up 16.9% year over year.

It holds more cash than debt, a net cash position of 440.07K CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 0.4000 CAD is 35.6% above the current price. The next earnings report is expected on 17 December 2026.